For the quarter ending 2025-12-31.
| Income Statement | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 |
|---|---|---|---|---|
| Revenues | 0 | 0 | 0 | - |
| Cost of sales | 0 | 0 | 0 | - |
| Gross profit | 0 | 0 | 0 | - |
| General and administrative | 185,876 | 244,434 | 81,683 | 65,467 |
| Professional fees | 289,144 | 246,521 | 454,344 | 603,695 |
| Other income (expense) | - | -5,000.75 | - | - |
| Total operating expenses | 475,020 | 490,955 | 536,027 | 669,162 |
| Recovery of previously written off receivables | - | 14,500 | - | - |
| Operating loss | -475,020 | -490,955 | -536,027 | -669,162 |
| Loss on extinguishment of debt | - | -10,782.333 | 0 | - |
| Interest income | 0 | - | 0 | - |
| Gain on sale of subsidiary assets | - | 0 | 0 | - |
| Other expense | 0 | - | - | - |
| Interest expense | 46,618 | 35,113 | 25,996 | 22,660 |
| Recovery of previously written off receivables | - | - | - | 50,000 |
| Total other expense, net | -46,618 | -67,460 | -25,996 | 27,340 |
| Net income from discontinued operations | - | 29,005 | - | - |
| Net loss before income taxes | -521,638 | -949,028 | -562,023 | -641,822 |
| Provision for income taxes | 0 | 361,608 | 0 | - |
| Net loss from continuing operations | - | - | -562,023 | -641,822 |
| Net income from discontinued operations, net of taxes | - | - | 0 | - |
| Net loss from continuing operations | - | -587,420 | - | - |
| Net loss | -521,638 | -558,415 | -562,023 | -641,822 |
| Net loss per share basic | 0 | 0 | 0 | -0.01 |
| Net loss per share diluted | 0 | 0 | 0 | -0.01 |
| Weighted average number of common shares outstanding basic | 151,713,129 | -257,504,931 | 136,951,495 | 131,081,825 |
| Weighted average number of common shares outstanding fully diluted | 151,713,129 | -257,504,931 | 136,951,495 | 131,081,825 |
Hypha Labs, Inc. (FUNI)
Hypha Labs, Inc. (FUNI)